Skip to content

Analgesic Efficacy of Transcutaneous Electrical Nerve Stimulation and Dexketoprofen in Renal Colic

Comparison of Analgesic Efficacy of Transcutaneous Electrical Nerve Stimulation and Dexketoprofen Trometamol in Patients Presenting to the Emergency Department With Renal Colic: A Randomized Controlled Trial

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07176572
Enrollment
128
Registered
2025-09-16
Start date
2026-03-01
Completion date
2026-12-31
Last updated
2025-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Colic

Keywords

Transcutaneous electrical nerve stimulation, emergency medicine, Dexketoprofen Trometamol

Brief summary

The aim of this study was to compare the analgesic efficacy of transcutaneous electrical nerve stimulation (TENS) and dexketoprofen trometamol in patients presenting to the emergency department due to renal colic.

Detailed description

Renal colic is a common presenting complaint to the emergency department and is an intensely painful condition. Parenteral opioids, non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol are commonly used to relieve the pain of renal colic. Dexketoprofen trometamol is a non-steroidal anti-inflammatory drug that is frequently used in the management of acute pain. Common and known side effects of nonsteroidal anti-inflammatory drugs include gastrointestinal system problems and allergic reactions. Transcutaneous electrical nerve stimulation is a non-invasive, non-pharmacological and low-risk treatment method. This study aimed to compare the analgesic efficacy of Transcutaneous electrical nerve stimulation and dexketoprofen trometamol in patients presenting to the emergency department with renal colic. Study Design and Setting: A prospective, randomized, double-blind, single-center, clinical trial will be conducted in emergency department of a tertiary care university hospital. Statistical Analysis: Categorical variables will be presented as numbers and percentages. The Kolmogorov-Smirnov test will be used to evaluate the normality of the distribution of continuous variables. Continuous variables with a non-normal distribution will be expressed as the median and interquartile range (IQR), and those with a normal distribution will be expressed as the mean and standard deviation (SD). The Mann-Whitney U test will be used to analyse non-normally distributed variables to evaluate the differences in visual analog scale scores between the two groups; the Student's t-test will be used for normally distributed variables. The sample size was calculated using the G\*Power 3.1.9.2 programme. According to the data obtained from the study of renal colic therapy with TENS, a difference of 18.4 mm in visual analogue scale score between the two groups with a standard deviation of 6 mm was assumed. It was calculated that 64 patients were required for each group with a two-sided critical value of α = 0.05, 95% power and an effect size of 0.5.

Interventions

DEVICETENS

Transcutaneous electrical nerve stimulation (TENS) treatment will be activated + NS IV Infusion 100 ml

50 mg dexketoprofen trometamol in 100 ml normal saline solution + Transcutaneous electrical nerve stimulation treatment will not be activated.

Sponsors

Adiyaman University Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Aged 18 years or over with a definite diagnosis of renal colic

Exclusion criteria

* Patients who refuse to participate in the study * Pregnant women * Breastfeeding women * Haemodynamically unstable * Evidence of peritoneal inflammation * Patients who were taking analgesics at the time of initial presentation * Unconsciousness or inability to communicate * Contraindications to applying TENS or using the drug in the study.

Design outcomes

Primary

MeasureTime frameDescription
Change of the intensity of pain15 minutes and 30 minutes after the administration of the study interventionsPain intense will be measured by 100 mm visual analog scale (Zero; no pain and 100 mm; the worst pain) after 15th and 30th minutes later the administration of the study interventions

Secondary

MeasureTime frameDescription
Adverse events30 minutes after30 minutes after the administration of the study interventions
need to rescue medication30 minutes after30 minutes after the administration of the study interventions

Countries

Turkey (Türkiye)

Contacts

Primary ContactUmut Gulacti, Prof.Dr.
umutgulacti@gmail.com+905355851900

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026